» Articles » PMID: 7534310

Self-coded 3'-extension of Run-off Transcripts Produces Aberrant Products During in Vitro Transcription with T7 RNA Polymerase

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1995 Mar 17
PMID 7534310
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

More than 70% of the RNA synthesized by T7 RNA polymerase during run-off transcription in vitro can be incorrect products, up to twice as long as the expected transcripts. Transcriptions with model templates indicate that false transcription is mainly observed when the correct product cannot form stable secondary structures at the 3'-end. Therefore, the following hypothesis is tested: after leaving the DNA template, the polymerase can bind a transcript to the template site and the 3'-end of the transcript to the product site and extend it, if the 3'-end is not part of a stable secondary structure. Indeed, incubation of purified transcripts with the polymerase in transcription conditions triggers a 3'-end prolongation of the RNA. When two RNAs of different lengths are added to the transcription mix, both generate distinct and specific patterns of prolonged RNA products without any interference, demonstrating the self-coding nature of the prolongation process. Furthermore, sequencing of the high molecular weight transcripts demonstrates that their 5'-ends are precisely defined in sequence, whereas the 3'-ends contain size-variable extensions which show complementarity to the correct transcript. Surprisingly, a reduction of the UTP concentration to 0.2-1.0 mM in the presence of 3.5-4.0 mM of the other NTPs leads to faithful transcription and good yields, irrespective of the nucleotide composition of the template.

Citing Articles

Design and Expression of Multiepitope Constructs Using mRNA Vaccine Technology.

Sanchez-Montejo J, Strilets T, Manzano-Roman R, Lopez-Aban J, Garcia-Blanco M, Vicente B Int J Mol Sci. 2025; 26(3).

PMID: 39940957 PMC: 11818309. DOI: 10.3390/ijms26031190.


Optimal Chimeric Antigen Receptor (CAR)-mRNA for Transient CAR T Cell Generation.

Kitte R, Serfling R, Blache U, Seitz C, Schrader S, Kohl U Int J Mol Sci. 2025; 26(3).

PMID: 39940734 PMC: 11818003. DOI: 10.3390/ijms26030965.


5' terminal nucleotide determines the immunogenicity of IVT RNAs.

Wolczyk M, Szymanski J, Trus I, Naz Z, Tame T, Bolembach A Nucleic Acids Res. 2024; 53(3).

PMID: 39704128 PMC: 11797061. DOI: 10.1093/nar/gkae1252.


Bacteriophage RNA polymerases: catalysts for mRNA vaccines and therapeutics.

Nair A, Kis Z Front Mol Biosci. 2024; 11:1504876.

PMID: 39640848 PMC: 11617373. DOI: 10.3389/fmolb.2024.1504876.


Production of Fully Capped mRNA for Transfection into Mammalian Cells: A Protocol for Enzymatic Degradation of Uncapped Transcripts After In Vitro mRNA Synthesis.

Jurkiewicz A, Graczyk D, Szczesny R Methods Mol Biol. 2024; 2863:107-115.

PMID: 39535707 DOI: 10.1007/978-1-0716-4176-7_8.